Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

In search of the most cost-effective monitoring strategy for vestibular schwannoma: A decision analytical modelling study.

Scholte M, Hentschel MA, Hannink G, Kunst HPM, Steens SC, Rovers MM, Grutters JPC.

Clin Otolaryngol. 2019 Mar 28. doi: 10.1111/coa.13326. [Epub ahead of print]

PMID:
30864276
2.
3.

The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.

Ector GICG, Govers TM, Westerweel PE, Grutters JPC, Blijlevens NMA.

Leuk Lymphoma. 2019 Jun;60(6):1485-1492. doi: 10.1080/10428194.2018.1535113. Epub 2019 Jan 22.

PMID:
30668187
4.

Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study.

Wijburg CJ, Michels CTJ, Oddens JR, Grutters JPC, Witjes JA, Rovers MM.

BMC Cancer. 2018 Sep 3;18(1):861. doi: 10.1186/s12885-018-4779-6.

5.

Integrated prediction and decision models are valuable in informing personalized decision making.

Govers TM, Rovers MM, Brands MT, Dronkers EAC, Baatenburg de Jong RJ, Merkx MAW, Takes RP, Grutters JPC.

J Clin Epidemiol. 2018 Dec;104:73-83. doi: 10.1016/j.jclinepi.2018.08.016. Epub 2018 Aug 28.

PMID:
30170106
6.

THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATION.

Rolden HJA, van der Wilt GJ, Maas AHEM, Grutters JPC.

Int J Technol Assess Health Care. 2018 Jan;34(3):327-336. doi: 10.1017/S0266462318000211. Epub 2018 Jun 18. Review.

PMID:
29909809
7.

A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research.

Michels CTJ, Wijburg CJ, Leijte E, Witjes JA, Rovers MM, Grutters JPC.

Eur Urol Focus. 2018 May 18. pii: S2405-4569(18)30104-4. doi: 10.1016/j.euf.2018.04.014. [Epub ahead of print]

PMID:
29779842
8.

The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective.

van Asten F, Michels CTJ, Hoyng CB, van der Wilt GJ, Klevering BJ, Rovers MM, Grutters JPC.

PLoS One. 2018 May 17;13(5):e0197670. doi: 10.1371/journal.pone.0197670. eCollection 2018.

9.

Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical research.

van der Wilt GJ, Grutters JPC, Maas AHEM, Rolden HJA.

BMC Med Ethics. 2018 Feb 5;19(1):5. doi: 10.1186/s12910-018-0245-x.

10.

Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed.

Rolden HJA, Maas AHEM, van der Wilt GJ, Grutters JPC.

BMC Cardiovasc Disord. 2017 Oct 13;17(1):260. doi: 10.1186/s12872-017-0692-1.

11.

The merits of decision modelling in the earliest stages of the IDEAL framework: An innovative case in DIEP flap breast reconstructions.

Hummelink S, Gerrits JGW, Schultze Kool LJ, Ulrich DJO, Rovers MM, Grutters JPC.

J Plast Reconstr Aesthet Surg. 2017 Dec;70(12):1696-1701. doi: 10.1016/j.bjps.2017.07.011. Epub 2017 Aug 7.

PMID:
28882494
12.

Potential savings in the diagnosis of vestibular schwannoma.

Scholte M, Hentschel MA, Kunst HP, Steens SCA, Rovers MM, Grutters JPC.

Clin Otolaryngol. 2018 Feb;43(1):285-290. doi: 10.1111/coa.12973. Epub 2017 Sep 7.

PMID:
28834261
13.

HEADROOM BEYOND THE QUALITY- ADJUSTED LIFE-YEAR: THE CASE OF COMPLEX PEDIATRIC NEUROLOGY.

van Nimwegen KJM, Lilford RJ, van der Wilt GJ, Grutters JPC.

Int J Technol Assess Health Care. 2017 Jan;33(1):5-10. doi: 10.1017/S0266462317000046. Epub 2017 May 30.

PMID:
28554333
14.

Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model.

Dijkstra S, Govers TM, Hendriks RJ, Schalken JA, Van Criekinge W, Van Neste L, Grutters JPC, Sedelaar JPM, van Oort IM.

BJU Int. 2017 Nov;120(5):659-665. doi: 10.1111/bju.13861. Epub 2017 Apr 29.

15.

Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.

van Nimwegen KJ, van Soest RA, Veltman JA, Nelen MR, van der Wilt GJ, Vissers LE, Grutters JP.

Clin Chem. 2016 Nov;62(11):1458-1464. Epub 2016 Sep 14.

16.

Intrathoracic versus Cervical ANastomosis after minimally invasive esophagectomy for esophageal cancer: study protocol of the ICAN randomized controlled trial.

van Workum F, Bouwense SA, Luyer MD, Nieuwenhuijzen GA, van der Peet DL, Daams F, Kouwenhoven EA, van Det MJ, van den Wildenberg FJ, Polat F, Gisbertz SS, Henegouwen MI, Heisterkamp J, Langenhoff BS, Martijnse IS, Grutters JP, Klarenbeek BR, Rovers MM, Rosman C.

Trials. 2016 Oct 18;17(1):505.

17.

Closing the information gap between clinical and postmarketing trials: the case of dabigatran.

Rolden HJ, Grutters JP, van der Wilt GJ, Maas AH.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):153-6. doi: 10.1093/ehjcvp/pvv020. Epub 2015 Apr 17. No abstract available. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):217.

PMID:
27533988
18.

Parental quality of life in complex paediatric neurologic disorders of unknown aetiology.

van Nimwegen KJ, Kievit W, van der Wilt GJ, Schieving JH, Willemsen MA, Donders AR, Verhaak CM, Grutters JP.

Eur J Paediatr Neurol. 2016 Sep;20(5):723-31. doi: 10.1016/j.ejpn.2016.05.007. Epub 2016 May 25.

PMID:
27321953
19.

Societal and Economic Effect of Meniscus Scaffold Procedures for Irreparable Meniscus Injuries.

Rongen JJ, Govers TM, Buma P, Grutters JP, Hannink G.

Am J Sports Med. 2016 Jul;44(7):1724-34. doi: 10.1177/0363546516639290. Epub 2016 Apr 19.

PMID:
27159309
20.

Network Meta-Analysis of Various Treatment Strategies in Resistant Hypertension.

Makai P, intHout J, Grutters JP, Deinum J, Jenniskens K, van der Wilt GJ.

Value Health. 2015 Nov;18(7):A377. doi: 10.1016/j.jval.2015.09.790. Epub 2015 Oct 20. No abstract available.

21.

Yearly hypertension screening in women with a history of pre-eclampsia: a cost-effectiveness analysis.

Drost JT, Grutters JP, van der Wilt GJ, van der Schouw YT, Maas AH.

Neth Heart J. 2015 Dec;23(12):585-91. doi: 10.1007/s12471-015-0760-z.

22.

Practice points in gynecardiology: Abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy.

Maas AH, Euler Mv, Bongers MY, Rolden HJ, Grutters JP, Ulrich L, Schenck-Gustafsson K.

Maturitas. 2015 Dec;82(4):355-9. doi: 10.1016/j.maturitas.2015.08.014. Epub 2015 Sep 1. Review.

PMID:
26358933
23.

The Authors' Reply: Comment on "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Grutters JP, van Asselt MB, Chalkidou K, Joore MA.

Pharmacoeconomics. 2015 Sep;33(9):983. doi: 10.1007/s40273-015-0321-8. No abstract available.

PMID:
26314283
24.

Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.

van Rijsingen MC, Seubring I, Grutters JP, Maessen-Visch MB, Alkemade HA, van Doorn R, Groenewoud H, van de Kerkhof PC, van der Wilt GJ, Gerritsen MJ.

Acta Derm Venereol. 2016 Mar;96(3):346-50. doi: 10.2340/00015555-2216.

25.

Quality of life after different procedures for regional control in oral cancer patients: cross-sectional survey.

Govers TM, Schreuder WH, Klop WM, Grutters JP, Rovers MM, Merkx MA, Takes RP.

Clin Otolaryngol. 2016 Jun;41(3):228-33. doi: 10.1111/coa.12502. Epub 2016 Feb 4.

PMID:
26198548
26.

Cost-effectiveness modelling in diagnostic imaging: a stepwise approach.

Sailer AM, van Zwam WH, Wildberger JE, Grutters JP.

Eur Radiol. 2015 Dec;25(12):3629-37. doi: 10.1007/s00330-015-3770-8. Epub 2015 May 24. Review.

27.

Women's and healthcare professionals' preferences for prenatal testing: a discrete choice experiment.

Beulen L, Grutters JP, Faas BH, Feenstra I, Groenewoud H, van Vugt JM, Bekker MN.

Prenat Diagn. 2015 Jun;35(6):549-57. doi: 10.1002/pd.4571. Epub 2015 Mar 13.

PMID:
25644120
28.

Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.

de Kinderen RJ, Postulart D, Aldenkamp AP, Evers SM, Lambrechts DA, Louw AJ, Majoie MH, Grutters JP.

Epilepsy Res. 2015 Feb;110:119-31. doi: 10.1016/j.eplepsyres.2014.12.005. Epub 2014 Dec 13.

PMID:
25616464
29.

The diagnostic pathway in complex paediatric neurology: a cost analysis.

van Nimwegen KJ, Schieving JH, Willemsen MA, Veltman JA, van der Burg S, van der Wilt GJ, Grutters JP.

Eur J Paediatr Neurol. 2015 Mar;19(2):233-9. doi: 10.1016/j.ejpn.2014.12.014. Epub 2014 Dec 29.

PMID:
25604808
30.

Surgical team composition has a major impact on effectiveness and costs in laparoscopic donor nephrectomy.

Özdemir-van Brunschot DM, Warlé MC, van der Jagt MF, Grutters JP, van Horne SB, Kloke HJ, van der Vliet JA, Langenhuijsen JF, d'Ancona FC.

World J Urol. 2015 May;33(5):733-41. doi: 10.1007/s00345-014-1428-9. Epub 2014 Nov 2.

PMID:
25362559
31.

The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.

Beulen L, Grutters JP, Faas BH, Feenstra I, van Vugt JM, Bekker MN.

Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:53-61. doi: 10.1016/j.ejogrb.2014.08.028. Epub 2014 Aug 30.

PMID:
25238658
32.

Healthy decisions: towards uncertainty tolerance in healthcare policy.

Grutters JP, van Asselt MB, Chalkidou K, Joore MA.

Pharmacoeconomics. 2015 Jan;33(1):1-4. doi: 10.1007/s40273-014-0201-7. No abstract available.

PMID:
25145801
34.

Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients.

Ramaekers BL, Joore MA, Lueza B, Bonastre J, Mauguen A, Pignon JP, Le Pechoux C, De Ruysscher DK; MAR-LC Collaborative group, Grutters JP.

J Thorac Oncol. 2013 Oct;8(10):1295-307. doi: 10.1097/JTO.0b013e31829f6c55.

35.

Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.

de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JP.

Eur Urol. 2014 Sep;66(3):430-6. doi: 10.1016/j.eururo.2013.12.012. Epub 2013 Dec 21.

PMID:
24377803
36.

Cost-effectiveness of early-initiated treatment for advanced-stage epithelial ovarian cancer patients: a modeling study.

Hoyer T, Bekkers R, Gooszen H, Massuger L, Rovers M, Grutters JP.

Int J Gynecol Cancer. 2014 Jan;24(1):75-84. doi: 10.1097/IGC.0000000000000025.

PMID:
24362714
37.

Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.

Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC.

J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28.

PMID:
24166522
38.

How should we deal with patient heterogeneity in economic evaluation: a systematic review of national pharmacoeconomic guidelines.

Ramaekers BL, Joore MA, Grutters JP.

Value Health. 2013 Jul-Aug;16(5):855-62. doi: 10.1016/j.jval.2013.02.013. Epub 2013 May 15. Review.

39.

Value of research and value of development in early assessments of new medical technologies.

Retèl VP, Grutters JP, van Harten WH, Joore MA.

Value Health. 2013 Jul-Aug;16(5):720-8. doi: 10.1016/j.jval.2013.04.013.

40.

Cost-effectiveness of CTA, MRA and DSA in patients with non-traumatic subarachnoid haemorrhage.

Sailer AM, Grutters JP, Wildberger JE, Hofman PA, Wilmink JT, van Zwam WH.

Insights Imaging. 2013 Aug;4(4):499-507. doi: 10.1007/s13244-013-0264-6. Epub 2013 Jul 10.

41.

What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?

Schlijper RC, Grutters JP, Houben R, Dingemans AM, Wildberger JE, Van Raemdonck D, Van Cutsem E, Haustermans K, Lammering G, Lambin P, De Ruysscher D.

Cancer Treat Rev. 2014 Feb;40(1):60-7. doi: 10.1016/j.ctrv.2013.05.004. Epub 2013 Jun 13. Review.

PMID:
23768754
42.

Cost-effectiveness of hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: a randomized study.

Klop KW, Kok NF, Dols LF, d'Ancona FC, Adang EM, Grutters JP, IJzermans JN.

Transplantation. 2013 Jul 27;96(2):170-5. doi: 10.1097/TP.0b013e318296ca25.

PMID:
23736351
43.

Management of the N0 neck in early stage oral squamous cell cancer: a modeling study of the cost-effectiveness.

Govers TM, Takes RP, Baris Karakullukcu M, Hannink G, Merkx MA, Grutters JP, Rovers MM.

Oral Oncol. 2013 Aug;49(8):771-7. doi: 10.1016/j.oraloncology.2013.05.001. Epub 2013 Jun 2.

PMID:
23735238
44.

Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.

Grutters JP, Sculpher M, Briggs AH, Severens JL, Candel MJ, Stahl JE, De Ruysscher D, Boer A, Ramaekers BL, Joore MA.

Pharmacoeconomics. 2013 Feb;31(2):111-23. doi: 10.1007/s40273-012-0015-4. Review.

PMID:
23329430
45.

Protons in head-and-neck cancer: bridging the gap of evidence.

Ramaekers BL, Grutters JP, Pijls-Johannesma M, Lambin P, Joore MA, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1282-8. doi: 10.1016/j.ijrobp.2012.11.006. Epub 2012 Dec 27.

46.

When to wait for more evidence? Real options analysis in proton therapy.

Grutters JP, Abrams KR, de Ruysscher D, Pijls-Johannesma M, Peters HJ, Beutner E, Lambin P, Joore MA.

Oncologist. 2011;16(12):1752-61. doi: 10.1634/theoncologist.2011-0029. Epub 2011 Dec 6.

47.

Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions.

Grutters JP, Seferina SC, Tjan-Heijnen VC, van Kampen RJ, Goettsch WG, Joore MA.

Value Health. 2011 Jul-Aug;14(5):777-84. doi: 10.1016/j.jval.2011.01.005. Review.

48.

The impact of late treatment-toxicity on generic health-related quality of life in head and neck cancer patients after radiotherapy.

Ramaekers BL, Joore MA, Grutters JP, van den Ende P, Jong Jd, Houben R, Lambin P, Christianen M, Beetz I, Pijls-Johannesma M, Langendijk JA.

Oral Oncol. 2011 Aug;47(8):768-74. doi: 10.1016/j.oraloncology.2011.05.012. Epub 2011 Jun 17.

49.

Health-related quality of life in patients surviving non-small cell lung cancer.

Grutters JP, Joore MA, Wiegman EM, Langendijk JA, de Ruysscher D, Hochstenbag M, Botterweck A, Lambin P, Pijls-Johannesma M.

Thorax. 2010 Oct;65(10):903-7. doi: 10.1136/thx.2010.136390.

PMID:
20861294
50.

Shared care for hearing complaints: guideline effects on patient flow.

Duijvestijn JA, Grutters JP, Chenault MN, Joore MA, Manni JJ, Anteunis LJ.

J Eval Clin Pract. 2011 Apr;17(2):209-14. doi: 10.1111/j.1365-2753.2010.01422.x. Epub 2010 Sep 16.

PMID:
20846280

Supplemental Content

Loading ...
Support Center